Ethnic variation of Fcγ receptor polymorphism in Sami and Norwegian populations

Immunology

Volumn 115, Issue 3, 2005, Pages 416-421

  Torkildsen, Øivind ^a   Utsi, Egil ^b   Mellgren, Svein Ivar ^c   Harbo, Hanne F ^d,e   Vedeler, Christian A ^a   Myhr, Kjell Morten ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b Karasjok Heart Center   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoimmunity; Ethnicity; Fc R; Immunoglobulin; Infectious disease

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIIA; FC RECEPTOR IIIB; UNCLASSIFIED DRUG;

ABORIGINE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORWAY; PRIORITY JOURNAL;

EID: 21244498647     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2005.02158.x     Document Type: Article

References (41)

1. Kimberly RP, Salmon JE, Edberg JC. Receptors for immunoglobulin G. Molecular diversity and implications for disease. Arthritis Rheum 1995; 38:306-14.
2. Salmom JE, Pricop L. Human receptors for immunoglobulin G. key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; 44:739-50.
3. Vedeler CA, Myhr KM, Nyland H. Fc receptors for immunoglobulin G - a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis. J Neuroimmunol 2001; 118:187-93.
4. Karassa FB, Trikalinos TA, Ioannidis JPA. The role of FcγRIIA and IIIA polymorphism in autoimmune disease. Biomed Pharmacother 2004; 58:286-91.
5. Yuan FF, Wong M, Pererva N, Keating J, Davis AR, Bryant JA, Sullivan JS. FcγRIIa polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2003; 81:192-5.
6. Domingo P, Muñiz-Diaz E, Baraldès MA et al. Relevance of genetically determined host factors to the prognosis of meningococcal disease. Eur J Clin Microbiol Infect Dis 2004; 23:634-7.
7. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S, Tokunaga K. Fcγ receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int 2002; 51:361-6.
8. Rekand T, Langeland N, Aarli JA, Vedeler CA. Fcγ receptor IIIA polymorphism as a risk factor for acute poliomyelitis. J Infect Dis 2002; 186:1840-3.
9. Louis E, El Ghoul Z, Vermeire S et al. Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther 2004; 19:511-9.
10. Gruel Y, Pouplard C, Lasne D, Magdelaine-Beuzelin C, Charroing C, Watier H. The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin/platelet factor 4 complexes. Blood 2004; 104:2791-3.
11. Yuan FF, Watson N, Sullivan JS, Biffin S, Moses J, Geczy AF, Chapman JR. Association of Fc gamma receptor IIa polymorphisms with acute renal-allograft rejection. Transplantation 2004; 78:766-9.
12. Warmerdam PAM, van de Winkel JGJ, Gosselin EJ, Capel PJA. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 1990; 172:19-25.
13. Bredius RG, Fijen CA, De Haas M, Kuijper EJ, Weening RS, Van de Winkel JG, Out TA. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 1994; 83:624-30.
14. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100:1059-70.
15. Koene HR, Kleijer M, Algra J, von Roos D, dem Borne AEGK, de Haas M. FcγRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell FcγRIIIa, independently of the FcγRIIIa-48L/R/H phenotype. Blood 1997; 90:1109-14.
16. Lehrnbecher T, Foster CB, Zhu S, Leitman SF, Goldin LR, Huppi K, Chanock SJ. Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations. Blood 1999; 94:4220-32.
17. Schie RCAA, Wilson ME. Evaluation of human FcγRIIA (CD32) and FcγIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin Diagn Lab Immunol 2000; 7:676-81.
18. Van Den Berg L, Myhr KM, Kluge B, Vedeler CA. Fcγ receptor polymorphisms in populations in Ethiopia and Norway. Immunology 2001; 104:87-91.
19. Carrington CVF, Norman PJ, Vaughan RW, Kondeatis E, Ramdath, DD, Hameed K, Stephens HA. Analysis of Fc gamma receptor II (CD32) polymorphisms in populations of African and South Asian ancestry reveals east-west geographic gradients of allele frequencies. Eur J Immunogenet 2003; 30:375-9.
20. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. Princeton: Princeton University Press, 1994.
21. Grønlie SA, Myrvoll E, Hansen G, Grønning M, Mellgren SI. Multiple sclerosis in north Norway, and first appearance in an indigenous population. J Neurol 2000; 247:129-33.
22. Falk ES. Atopic disease in Norwegian Lapps. Acta Derm Venereol Suppl 1993; 182:10-4.
23. Johnsen K, Gran JT, Dale K, Husby G. The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol 1992; 19:1591-4.
24. Botto M, Theodoridis E, Thompson EM et al. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 1996; 104:264-8.
25. Leppers-van de Straat FGJ, van der Pol WL, Jansen MD et al. A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping. J Immunol Meth 2000; 242:127-32.
26. Bux J, Stein EL, Santoso S, Mueller-Eckhardt C. NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific priemrs. Transfusion 1995; 35:54-7.
27. Van der Pol WL, Jansen MD, Sluiter WJ et al. Evidence for non-random distribution of Fcγ receptor genotype combinations. Immunogenetics 2003; 55:240-6.
28. Van der Pol W, Van de Winkel JGJ. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998; 48:222-32.
29. Myhr KM, Raknes G, Nyland H, Vedeler C. Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS. Neurology 1999; 52:1771-6.
30. Tambets K, Rootsi S, Kivisild T et al. The western and eastern roots of the Sami - the story of genetic 'outliers' told by mitochondrial DNA and Y chromosomes. Am J Hum Genet 2004; 74:661-82.
31. Edberg JC, Langefeld CD, Wu J et al. Genetic linkage and association of Fcγ receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 2002; 46:2132-40.
32. Schnackenberg L, Flesch BK, Neppert J. Linkage disequilibria between Duffy blood groups, Fc gamma IIa and Fc gamma IIIb allotypes. Exp Clin Immunogenet 1997; 14:235-42.
33. Grønning M, Mellgren SI. Multiple sclerosis in the two northernmost counties of Norway. Acta Neurol Scand 1985; 72:321-7.
34. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22:117-39.
35. Edberg JC, Kimberly RP. Modulation of Fcγ and complement receptor function by the glycosyl-phosphatidylinositol anchored form of FcγRIII. J Immunol 1994; 152:5826-35.
36. Breij ECW, van der Pol WL, van Winsen L, Jansen MD, Dijkstra CD, van de Winkel JG, Uitdehaag BM. No association of FcγRIIa, FcγRIIIa and FcγRIIIb polymorphisms with MS. J Neuroimmunol 2003; 140:210-5.
37. Thorsby E, Bartlie A, Teisberg P. HL-A polymorphism of Norwegian Lapps. Tissue Antigens 1971; 1:137-46.
38. Pawlik A, Carlson L, Meisel P, Czaja-Bulsa G, Mokrzycka M, Gawronska-Szklarz B. The FcγRIIa polymorphism in children with atopic disease. Int Arch Allergy Immunol 2004; 133:233-8.
39. Brun JG, Madland TM, Vedeler CA. Immunoglobulin G Fc receptor (FcγR) IIA IIIA and IIIB polymorphisms related to the severity in rheumatoid arthritis. J Rheumatol 2002; 29:1135-40.
40. Morgan AW, Keyte VH, Babbage SJ et al. FcγRIIIA-158V and rheumatoid arthritis: a confirmation study. Rheumatology (Oxford) 2003; 42:528-33.
41. Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 1990; 81:357-67.